Celgene Corp (CELG) 117.38 $CELG
Celgene Announces New Data for OTEZLA(R) (Apremilast) Will Be Presented at European Academy of Dermatology and Venereology Congress
Business Wire - Fri Oct 09, 6:30AM CDT
--Physician's Global Assessment and Body Surface Area (PGAxBSA) composite tool evaluated for the assessment of disease severity and response to OTEZLA in ESTEEM 1
CELG: 117.38 (-0.59), CELGZ: 1.74 (+0.04)
'Fast Money' Recap: Avoid Alcoa on Its Disappointing Earnings
at The Street - Fri Oct 09, 4:00AM CDT
The trading panel discussed biotech stocks and Netflix' subscription rate increase.
NFLX: 113.33 (-1.60), BIIB: 269.16 (-10.72), AA: 10.26 (-0.75), SPY: 201.33 (+0.12), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), RGLS: 6.86 (+0.29), CELG: 117.38 (-0.59)
Everything Wants to Go Up at the Same Time
at The Street - Thu Oct 08, 12:18PM CDT
This rolling bear market can be deceptive.
MMM: 149.90 (+0.42), GE: 28.07 (+0.04), CLX: 120.52 (+0.34), HON: 101.16 (+0.09), KMB: 114.73 (+0.93), PSTG: 16.60 (+0.67), M: 51.00 (-0.47), XOM: 79.26 (-0.77), BWLD: 196.14 (-1.07), JNPR: 29.40 (-0.40), JACK: 77.41 (+1.62), ECA: 8.76 (-0.26), IBM: 152.39 (+0.11), CMG: 732.93 (-1.84), TGT: 78.88 (+0.19), COST: 153.97 (+2.31), GOOGL: 671.24 (+4.24), EMC: 27.86 (+0.68), TWTR: 30.85 (+0.53), AAPL: 112.12 (+2.62), MBLY: 49.27 (+1.38), UNP: 97.04 (-0.01), CSCO: 27.91 (unch), GPRO: 29.08 (+1.48), AMZN: 539.80 (+6.64), SWKS: 79.50 (+0.07), FB: 93.24 (+0.77), BA: 139.70 (+0.66), HPQ: 29.30 (+0.12), DIN: 91.64 (+0.08), CELG: 117.38 (-0.59), DENN: 11.19 (+0.09), NFLX: 113.33 (-1.60), GILD: 100.65 (-0.16), MCD: 102.76 (-0.19), PG: 74.48 (+0.08), MRO: 19.59 (-0.59), CVX: 89.57 (-0.34)
Stock Market News for October 08, 2015
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 9:10AM CDT
Benchmarks ended Wednesday’s choppy trading session in the green boosted by gains in biotechnology companies
KMI: 32.35 (-0.33), BIIB: 269.16 (-10.72), MON: 89.70 (+0.45), COP: 56.10 (-0.18), AMGN: 149.59 (-0.31), BA: 139.70 (+0.66), CELG: 117.38 (-0.59), LYB: 95.45 (-2.05), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), CVX: 89.57 (-0.34), DOW: 47.08 (-0.71), REGN: 503.92 (+12.71), ECL: 120.54 (+0.01), YUM: 70.25 (+2.79)
Biogen Caused Biotech Collapse but Might Also Lead Stocks Higher
at The Street - Thu Oct 08, 7:49AM CDT
Biogen has the opportunity to make amends for its second-quarter earnings blow-up when it reports third-quarter earnings in two weeks.
BIIB: 269.16 (-10.72), GILD: 100.65 (-0.16), IBB: 308.45 (+1.25), AMGN: 149.59 (-0.31), CELG: 117.38 (-0.59)
Concert Pharmaceuticals Announces $8 Million Milestone from Celgene
Business Wire - Thu Oct 08, 6:00AM CDT
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has achieved an $8 million milestone under its development and license agreement with Celgene Corporation (NASDAQ: CELG) for completion of the Phase 1 clinical evaluation of CTP-730. CTP-730 is a deuterium-modified analog of apremilast, a selective phosphodiesterase 4 (PDE4) inhibitor. Once-daily dosing of 50 mg of CTP-730 administered for 7 days in the Phase 1 trial demonstrated similar steady-state exposure to historical data for 30 mg of apremilast administered twice daily.
CNCE: 20.87 (+0.62), CELG: 117.38 (-0.59), CELGZ: 1.74 (+0.04)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 4.28% Gain
Comtex SmarTrend(R) - Wed Oct 07, 3:47PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 117.38 (-0.59)
After Yesterday's Rally of 4.28% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 07, 3:47PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 117.38 (-0.59)
Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities
at The Street - Wed Oct 07, 11:59AM CDT
Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.
BLUE: 88.80 (+0.30), BIIB: 269.16 (-10.72), FB: 93.24 (+0.77), XOM: 79.26 (-0.77), AMGN: 149.59 (-0.31), LLY: 86.14 (+2.37), BMY: 61.44 (+0.93), INTC: 32.14 (-0.38), CELG: 117.38 (-0.59), WWAV: 43.82 (+2.11), MSFT: 47.11 (-0.34), TWTR: 30.85 (+0.53), CVX: 89.57 (-0.34), GIS: 56.61 (+0.13)
Shares of CELG Down 8.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 07, 10:24AM CDT
SmarTrend identified a Downtrend for Celgene (NASDAQ:CELG) on August 7th, 2015 at $126.90. In approximately 2 months, Celgene has returned 8.92% as of today's recent price of $115.58.
CELG: 117.38 (-0.59)
Jim Cramer -- Take Cisco Over Juniper and Buy Celgene, Too
at The Street - Wed Oct 07, 10:24AM CDT
Cramer likes Cisco Systems' low valuation and exposure to the cyber security industry. He loves Celgene for its above-average growth and reasonable valuation.
IBB: 308.45 (+1.25), CSCO: 27.91 (unch), CELG: 117.38 (-0.59), JNPR: 29.40 (-0.40)
Celgene (CELG) Crosses Pivot Point Resistance at $115.86
Comtex SmarTrend(R) - Wed Oct 07, 9:04AM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $112.26 today and has reached the first level of resistance at $115.86. Investors may be interested in a cross of the next upside pivot targets of $119.53 and $126.80.
CELG: 117.38 (-0.59)
Biotech's Bloodbath Is Ridiculous; Here's Why
George Budwell, The Motley Fool - Motley Fool - Wed Oct 07, 7:43AM CDT
Biotech has had an absolutely terrible time over the last few months, with most of the top dogs in the industry seeing their share prices get some pretty ugly haircuts: GILD data by YCharts . The odd and perhaps ridiculous part of...
GILD: 100.65 (-0.16), CELG: 117.38 (-0.59)
Drug Stocks' Earnings Power Won't Go Away
at The Street - Wed Oct 07, 4:23AM CDT
Before you sell them, ask yourself at what multiple you sell.
AGN: 274.84 (-1.32), JNJ: 95.37 (+0.29), ABT: 41.89 (+0.73), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), RCPT: 231.96 (-0.03), TEVA: 58.96 (-0.28), REGN: 503.92 (+12.71), CELG: 117.38 (-0.59)
DuPont and Illumina are big market movers
AP - Tue Oct 06, 3:44PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
GE: 28.07 (+0.04), SWKS: 79.50 (+0.07), ILMN: 147.77 (+7.40), TCS: 11.90 (+0.15), CELG: 117.38 (-0.59), PEP: 99.47 (+0.50), AA: 10.26 (-0.75), NWL: 42.22 (-0.20), ONCE: 49.30 (+1.86), DE: 79.87 (-1.04), DD: 56.18 (+0.05), BP: 35.96 (unch), TWTR: 30.85 (+0.53), GIS: 56.61 (+0.13)
Biotech stocks fall on trade deal and drug price scrutiny
By MARLEY JAY - AP - Tue Oct 06, 3:11PM CDT
NEW YORK (AP) — Biotech stocks slipped Tuesday on concerns about patent protection overseas and on continued scrutiny of the cost of some medications.
VRTX: 110.00 (+0.97), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), REGN: 503.92 (+12.71), MS: 32.72 (-0.27), CELG: 117.38 (-0.59)
Jim Cramer -- Peltz Will Be Great for GE, Amazon Can't Hurt Apple TV
at The Street - Tue Oct 06, 11:19AM CDT
On Tuesday, Jim Cramer discussed what's ahead for the stock market, why you should own General Electric, and why he's a fan of Columbia Sportswear.
BIIB: 269.16 (-10.72), AMZN: 539.80 (+6.64), GE: 28.07 (+0.04), VFC: 71.36 (+0.03), COLM: 58.42 (-0.32), XOM: 79.26 (-0.77), LULU: 52.75 (-1.46), PEP: 99.47 (+0.50), CELG: 117.38 (-0.59), JNJ: 95.37 (+0.29), AA: 10.26 (-0.75), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), AAPL: 112.12 (+2.62)
'Mad Money' Lightning Round: Hurray, Change Is Finally Coming to Twitter
at The Street - Tue Oct 06, 5:00AM CDT
Cramer wants you to avoid Sprint, Intrexon and Motorola Solutions.
MSI: 68.78 (-0.72), SWIR: 24.17 (-0.01), GOGO: 17.04 (+0.05), SWKS: 79.50 (+0.07), S: 4.47 (-0.08), IP: 43.23 (+2.14), XON: 36.01 (+1.24), AMAG: 40.06 (+1.32), TWTR: 30.85 (+0.53), CELG: 117.38 (-0.59), UAL: 55.71 (+3.45)
'Fast Money' Recap: Have Markets Risen Too Far Too Fast?
at The Street - Tue Oct 06, 4:00AM CDT
The trading panel discussed Dupont, Norman Peltz and if today's stock market is acting like 2011's.
SPY: 201.33 (+0.12), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), IBB: 308.45 (+1.25), CELG: 117.38 (-0.59)
Celgene Announces New Data for OTEZLA(R) (Apremilast) Will Be Presented at European Academy of Dermatology and Venereology Congress
Business Wire - Fri Oct 09, 6:30AM CDT
--Physician's Global Assessment and Body Surface Area (PGAxBSA) composite tool evaluated for the assessment of disease severity and response to OTEZLA in ESTEEM 1
CELG: 117.38 (-0.59), CELGZ: 1.74 (+0.04)
'Fast Money' Recap: Avoid Alcoa on Its Disappointing Earnings
at The Street - Fri Oct 09, 4:00AM CDT
The trading panel discussed biotech stocks and Netflix' subscription rate increase.
NFLX: 113.33 (-1.60), BIIB: 269.16 (-10.72), AA: 10.26 (-0.75), SPY: 201.33 (+0.12), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), RGLS: 6.86 (+0.29), CELG: 117.38 (-0.59)
Everything Wants to Go Up at the Same Time
at The Street - Thu Oct 08, 12:18PM CDT
This rolling bear market can be deceptive.
MMM: 149.90 (+0.42), GE: 28.07 (+0.04), CLX: 120.52 (+0.34), HON: 101.16 (+0.09), KMB: 114.73 (+0.93), PSTG: 16.60 (+0.67), M: 51.00 (-0.47), XOM: 79.26 (-0.77), BWLD: 196.14 (-1.07), JNPR: 29.40 (-0.40), JACK: 77.41 (+1.62), ECA: 8.76 (-0.26), IBM: 152.39 (+0.11), CMG: 732.93 (-1.84), TGT: 78.88 (+0.19), COST: 153.97 (+2.31), GOOGL: 671.24 (+4.24), EMC: 27.86 (+0.68), TWTR: 30.85 (+0.53), AAPL: 112.12 (+2.62), MBLY: 49.27 (+1.38), UNP: 97.04 (-0.01), CSCO: 27.91 (unch), GPRO: 29.08 (+1.48), AMZN: 539.80 (+6.64), SWKS: 79.50 (+0.07), FB: 93.24 (+0.77), BA: 139.70 (+0.66), HPQ: 29.30 (+0.12), DIN: 91.64 (+0.08), CELG: 117.38 (-0.59), DENN: 11.19 (+0.09), NFLX: 113.33 (-1.60), GILD: 100.65 (-0.16), MCD: 102.76 (-0.19), PG: 74.48 (+0.08), MRO: 19.59 (-0.59), CVX: 89.57 (-0.34)
Stock Market News for October 08, 2015
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 9:10AM CDT
Benchmarks ended Wednesday’s choppy trading session in the green boosted by gains in biotechnology companies
KMI: 32.35 (-0.33), BIIB: 269.16 (-10.72), MON: 89.70 (+0.45), COP: 56.10 (-0.18), AMGN: 149.59 (-0.31), BA: 139.70 (+0.66), CELG: 117.38 (-0.59), LYB: 95.45 (-2.05), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), CVX: 89.57 (-0.34), DOW: 47.08 (-0.71), REGN: 503.92 (+12.71), ECL: 120.54 (+0.01), YUM: 70.25 (+2.79)
Biogen Caused Biotech Collapse but Might Also Lead Stocks Higher
at The Street - Thu Oct 08, 7:49AM CDT
Biogen has the opportunity to make amends for its second-quarter earnings blow-up when it reports third-quarter earnings in two weeks.
BIIB: 269.16 (-10.72), GILD: 100.65 (-0.16), IBB: 308.45 (+1.25), AMGN: 149.59 (-0.31), CELG: 117.38 (-0.59)
Concert Pharmaceuticals Announces $8 Million Milestone from Celgene
Business Wire - Thu Oct 08, 6:00AM CDT
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has achieved an $8 million milestone under its development and license agreement with Celgene Corporation (NASDAQ: CELG) for completion of the Phase 1 clinical evaluation of CTP-730. CTP-730 is a deuterium-modified analog of apremilast, a selective phosphodiesterase 4 (PDE4) inhibitor. Once-daily dosing of 50 mg of CTP-730 administered for 7 days in the Phase 1 trial demonstrated similar steady-state exposure to historical data for 30 mg of apremilast administered twice daily.
CNCE: 20.87 (+0.62), CELG: 117.38 (-0.59), CELGZ: 1.74 (+0.04)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 4.28% Gain
Comtex SmarTrend(R) - Wed Oct 07, 3:47PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 117.38 (-0.59)
After Yesterday's Rally of 4.28% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 07, 3:47PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $110.88 to a high of $118.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $118.41 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 117.38 (-0.59)
Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities
at The Street - Wed Oct 07, 11:59AM CDT
Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.
BLUE: 88.80 (+0.30), BIIB: 269.16 (-10.72), FB: 93.24 (+0.77), XOM: 79.26 (-0.77), AMGN: 149.59 (-0.31), LLY: 86.14 (+2.37), BMY: 61.44 (+0.93), INTC: 32.14 (-0.38), CELG: 117.38 (-0.59), WWAV: 43.82 (+2.11), MSFT: 47.11 (-0.34), TWTR: 30.85 (+0.53), CVX: 89.57 (-0.34), GIS: 56.61 (+0.13)
Shares of CELG Down 8.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 07, 10:24AM CDT
SmarTrend identified a Downtrend for Celgene (NASDAQ:CELG) on August 7th, 2015 at $126.90. In approximately 2 months, Celgene has returned 8.92% as of today's recent price of $115.58.
CELG: 117.38 (-0.59)
Jim Cramer -- Take Cisco Over Juniper and Buy Celgene, Too
at The Street - Wed Oct 07, 10:24AM CDT
Cramer likes Cisco Systems' low valuation and exposure to the cyber security industry. He loves Celgene for its above-average growth and reasonable valuation.
IBB: 308.45 (+1.25), CSCO: 27.91 (unch), CELG: 117.38 (-0.59), JNPR: 29.40 (-0.40)
Celgene (CELG) Crosses Pivot Point Resistance at $115.86
Comtex SmarTrend(R) - Wed Oct 07, 9:04AM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $112.26 today and has reached the first level of resistance at $115.86. Investors may be interested in a cross of the next upside pivot targets of $119.53 and $126.80.
CELG: 117.38 (-0.59)
Biotech's Bloodbath Is Ridiculous; Here's Why
George Budwell, The Motley Fool - Motley Fool - Wed Oct 07, 7:43AM CDT
Biotech has had an absolutely terrible time over the last few months, with most of the top dogs in the industry seeing their share prices get some pretty ugly haircuts: GILD data by YCharts . The odd and perhaps ridiculous part of...
GILD: 100.65 (-0.16), CELG: 117.38 (-0.59)
Drug Stocks' Earnings Power Won't Go Away
at The Street - Wed Oct 07, 4:23AM CDT
Before you sell them, ask yourself at what multiple you sell.
AGN: 274.84 (-1.32), JNJ: 95.37 (+0.29), ABT: 41.89 (+0.73), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), RCPT: 231.96 (-0.03), TEVA: 58.96 (-0.28), REGN: 503.92 (+12.71), CELG: 117.38 (-0.59)
DuPont and Illumina are big market movers
AP - Tue Oct 06, 3:44PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
GE: 28.07 (+0.04), SWKS: 79.50 (+0.07), ILMN: 147.77 (+7.40), TCS: 11.90 (+0.15), CELG: 117.38 (-0.59), PEP: 99.47 (+0.50), AA: 10.26 (-0.75), NWL: 42.22 (-0.20), ONCE: 49.30 (+1.86), DE: 79.87 (-1.04), DD: 56.18 (+0.05), BP: 35.96 (unch), TWTR: 30.85 (+0.53), GIS: 56.61 (+0.13)
Biotech stocks fall on trade deal and drug price scrutiny
By MARLEY JAY - AP - Tue Oct 06, 3:11PM CDT
NEW YORK (AP) — Biotech stocks slipped Tuesday on concerns about patent protection overseas and on continued scrutiny of the cost of some medications.
VRTX: 110.00 (+0.97), GILD: 100.65 (-0.16), AMGN: 149.59 (-0.31), REGN: 503.92 (+12.71), MS: 32.72 (-0.27), CELG: 117.38 (-0.59)
Jim Cramer -- Peltz Will Be Great for GE, Amazon Can't Hurt Apple TV
at The Street - Tue Oct 06, 11:19AM CDT
On Tuesday, Jim Cramer discussed what's ahead for the stock market, why you should own General Electric, and why he's a fan of Columbia Sportswear.
BIIB: 269.16 (-10.72), AMZN: 539.80 (+6.64), GE: 28.07 (+0.04), VFC: 71.36 (+0.03), COLM: 58.42 (-0.32), XOM: 79.26 (-0.77), LULU: 52.75 (-1.46), PEP: 99.47 (+0.50), CELG: 117.38 (-0.59), JNJ: 95.37 (+0.29), AA: 10.26 (-0.75), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), AAPL: 112.12 (+2.62)
'Mad Money' Lightning Round: Hurray, Change Is Finally Coming to Twitter
at The Street - Tue Oct 06, 5:00AM CDT
Cramer wants you to avoid Sprint, Intrexon and Motorola Solutions.
MSI: 68.78 (-0.72), SWIR: 24.17 (-0.01), GOGO: 17.04 (+0.05), SWKS: 79.50 (+0.07), S: 4.47 (-0.08), IP: 43.23 (+2.14), XON: 36.01 (+1.24), AMAG: 40.06 (+1.32), TWTR: 30.85 (+0.53), CELG: 117.38 (-0.59), UAL: 55.71 (+3.45)
'Fast Money' Recap: Have Markets Risen Too Far Too Fast?
at The Street - Tue Oct 06, 4:00AM CDT
The trading panel discussed Dupont, Norman Peltz and if today's stock market is acting like 2011's.
SPY: 201.33 (+0.12), GILD: 100.65 (-0.16), DD: 56.18 (+0.05), IBB: 308.45 (+1.25), CELG: 117.38 (-0.59)
